Transfer of topical testosterone preparations to children or spouses

Journal of Sexual Medicine

Volumn 6, Issue 10, 2009, Pages 2649-2652

  Lewis, Tyler ^a   Goldstein, Irwin ^b  

^a ALVARADO HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE; ANDROGEN; GEL;

ACNE; ANDROGEN DEFICIENCY; BONE MASS; CHILD HEALTH; CLITOROMEGALY; CREAM; DRUG CONTRAINDICATION; DRUG EXPOSURE; DRUG SAFETY; HAIR; HAIR GROWTH; HUMAN; HYPOGONADISM; NOTE; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PUBERTY DISORDERS; PUBIC HAIR; SEXUAL EDUCATION; SEXUAL FUNCTION; SEXUAL HEALTH; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; ADULT; ADVERSE DRUG REACTION; CHILD; CHILD WELFARE; FATHER CHILD RELATION; FEMALE; GEL; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; SPOUSE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; ANDROGENS; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FATHER-CHILD RELATIONS; FEMALE; GELS; HUMANS; INFANT; MALE; MIDDLE AGED; SPOUSES; TESTOSTERONE;

EID: 70649091386     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01478.x     Document Type: Article

References (22)

1. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 2000, 85:2839-53.
2. McNicholas TA, Dean JD, Mulder H, Carnegie C, Jones NA. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int 2003, 91:69-74.
3. Guay AT, Smith TM, Offutt LA. J Sex Med. 2009, doi: 10.1111/j.1743-6109.2009.01366.x
4. Reyes-Vallejo L, Lazarou S, Morgentaler A. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone. J Sex Med 2007, 4:1757-62.
5. Amano T, Imao T, Takemae K, Iwamoto T, Yamakawa K, Baba K, Nakanome M, Sugimori H, Tanaka T, Yoshida K, Katabami T, Tanaka M. Profile of serum testosterone levels after application of testosterone ointment (glowmin) and its clinical efficacy in late-onset hypogonadism patients. J Sex Med 2008, 5:1727-36.
6. Khera M. Androgens and erectile function: A case for early androgen use in postprostatectomy hypogonadal men. J Sex Med 2009, 6:S234-8.
7. Khera M, Grober ED, Najari B, Colen JS, Mohamed O, Lamb DJ, Lipshultz LI. Testosterone replacement therapy following radical prostatectomy. J Sex Med 2009, 6:1165-70.
8. Spielberg TE. Abnormal testosterone levels in partners of patients using testosterone gels. J Sex Med 2005, 2:278.
9. Mazer N, Fisher D, Fischer J, Cosgrove M, Bell D, Eilers B. Transfer of transdermally applied testosterone to clothing: A comparison of a testosterone patch versus a testosterone gel. J Sex Med 2005, 2:227-34.
10. Hackett G, Kell P, Ralph D, Dean J, Price D, Speakman M, Wylie K. British Society for Sexual Medicine. British Society for Sexual Medicine guidelines on the management of erectile dysfunction. J Sex Med 2008, 5:1841-65.
11. O'Connor DB, Corona G, Forti G, Tajar A, Lee DM, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Huhtaniemi IT, Kula K, O'Neill TW, Pendleton N, Punab M, Silman AJ, Vanderschueren D, Wu FC. Assessment of sexual health in aging men in Europe: Development and validation of the European Male Ageing Study sexual function questionnaire. J Sex Med 2008, 5:1374-85.
12. Corona G, Jannini EA, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G, Bandini E, Chiarini V, Forti G, Maggi M. Different testosterone levels are associated with ejaculatory dysfunction. J Sex Med 2008, 5:1991-8.
13. Corona G, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G, Bandini E, Forti G, Maggi M. Low levels of androgens in men with erectile dysfunction and obesity. J Sex Med 2008, 5:2454-63.
14. Maggi M, Schulman C, Quinton R, Langham S, Uhl-Hochgraeber K. The burden of testosterone deficiency syndrome in adult men: Economic and quality-of-life impact. J Sex Med 2007, 4:1056-69.
15. Guay A, Jacobson J. The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction. J Sex Med 2007, 4:1046-55.
16. Corona G, Mannucci E, Petrone L, Balercia G, Paggi F, Fisher AD, Lotti F, Chiarini V, Fedele D, Forti G, Maggi M. NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med 2007, 4:1038-45.
17. Stephen MD, Jehaimi CT, Brosnan PG, Yafi M. Sexual precocity in a 2-year old boy caused by indirect exposure to testosterone cream. Endocr Pract 2008, 14:1027-30.
18. Kunz GJ, Klein KO, Clemons RD, Gottschalk ME, Jones KL. Virilization of young children after topical androgen use by their parents. Pediatrics 2004, 114:282-7.
19. Bhowlick SK, Ricke T, Rettig KR. Sexual precocity in a 16-month old boy induced by indirect topical exposure to testosterone. Clin Ped 2007, 46:540-3.
20. Androgel (testosterone) OSE safety review. 2009, http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM166660.pdf, FDA Center for Drug Evaluation and Research, Available at: (accessed July 12, 2009
21. Merhi ZO, Santoro N. Postmenopausal virilization after spousal use of topical androgens. Fertil Steril 2007, 87:976-8.
22. de Ronde W. Hyperandrogenism after transfer of topical testosterone gel: Case report and review of published and unpublished studies. Hum Reprod 2009, 24:425-8.